购物车
- 全部删除
- 您的购物车当前为空
CDK2 degrader1 (Compound 3) 属于PROTAC技术开发的口服cyclin-dependent kinase 2 (CDK2)降解剂.该化合物通过与小脑结合,引发CDK2的泛素化,进而促进其通过蛋白酶体途径的降解.CDK2 degrader1 主要应用于不同癌症类型的研究中.
CDK2 degrader1 (Compound 3) 属于PROTAC技术开发的口服cyclin-dependent kinase 2 (CDK2)降解剂.该化合物通过与小脑结合,引发CDK2的泛素化,进而促进其通过蛋白酶体途径的降解.CDK2 degrader1 主要应用于不同癌症类型的研究中.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | CDK2 degrader1 (Compound 3) is an orally active cyclin-dependent kinase 2 (CDK2) degrader based on PROTAC technology. It binds to cerebellum, inducing ubiquitination of CDK2 followed by proteasomal degradation pathway. CDK2 degrader1 is utilized in the research of multiple cancers. |
分子量 | 447.48 |
分子式 | C23H27F2N3O4 |
CAS No. | 3036604-59-5 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容